Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00577746 · ClinicalTrials.gov registry record
Clinical Impact of EUS in Staging NSCLC
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 110
- Enrollment target
NCT00577746: Completed study, sponsored by Indiana University.
NCT00577746 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00577746 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
The goal of this prospective study is to determine the clinical and economic impact of endoscopic ultrasound (EUS) in staging NSCLC. Aims: 1) Determine the accuracy of EUS in staging NSCLC 2) Measure 5-year survival 3) Measure quality of life in patients that undergo surgery 4) Determine the cost benefit of EUS in staging NSCLC.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2006-06 |
| Est. Completion | 2013-09 |
What the finished NCT00577746 record still lists
NCT00577746 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00577746 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00577746 about?
NCT00577746 is a clinical study titled "Clinical Impact of EUS in Staging NSCLC". The goal of this prospective study is to determine the clinical and economic impact of endoscopic ultrasound (EUS) in staging NSCLC. Aims: 1) Determine the accuracy of EUS in staging NSCLC 2) Measure 5-year survival 3) Measure quality of life in patients that undergo surgery 4) Determine the cost be...
What is the current status of trial NCT00577746?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2006-06. Estimated completion is 2013-09.
Who is sponsoring clinical trial NCT00577746?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia